176 related articles for article (PubMed ID: 34031132)
1. Precursor Abundance Influences Divergent Antigen-Specific CD8
Zhang Y; Qiu Z; Sheridan BS; Bliska JB
Infect Immun; 2021 Jul; 89(8):e0026521. PubMed ID: 34031132
[TBL] [Abstract][Full Text] [Related]
2. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
[TBL] [Abstract][Full Text] [Related]
3. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
[TBL] [Abstract][Full Text] [Related]
4. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
[TBL] [Abstract][Full Text] [Related]
5. CCR2
Zhang Y; Khairallah C; Sheridan BS; van der Velden AWM; Bliska JB
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263104
[TBL] [Abstract][Full Text] [Related]
6. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.
Zhang Y; Mena P; Romanov G; Bliska JB
Infect Immun; 2014 Jul; 82(7):3033-44. PubMed ID: 24799630
[TBL] [Abstract][Full Text] [Related]
7. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
[TBL] [Abstract][Full Text] [Related]
8. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.
Bergman MA; Loomis WP; Mecsas J; Starnbach MN; Isberg RR
PLoS Pathog; 2009 Sep; 5(9):e1000573. PubMed ID: 19730693
[TBL] [Abstract][Full Text] [Related]
9. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
10. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
[TBL] [Abstract][Full Text] [Related]
12. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
13. Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling.
Pasztoi M; Bonifacius A; Pezoldt J; Kulkarni D; Niemz J; Yang J; Teich R; Hajek J; Pisano F; Rohde M; Dersch P; Huehn J
Cell Mol Life Sci; 2017 Aug; 74(15):2839-2850. PubMed ID: 28378044
[TBL] [Abstract][Full Text] [Related]
14. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes.
Bliska JB; Brodsky IE; Mecsas J
EcoSal Plus; 2021 Dec; 9(2):eESP00142021. PubMed ID: 34910573
[TBL] [Abstract][Full Text] [Related]
15. White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection.
Han SJ; Glatman Zaretsky A; Andrade-Oliveira V; Collins N; Dzutsev A; Shaik J; Morais da Fonseca D; Harrison OJ; Tamoutounour S; Byrd AL; Smelkinson M; Bouladoux N; Bliska JB; Brenchley JM; Brodsky IE; Belkaid Y
Immunity; 2017 Dec; 47(6):1154-1168.e6. PubMed ID: 29221731
[TBL] [Abstract][Full Text] [Related]
16. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
[TBL] [Abstract][Full Text] [Related]
17. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
Westermark L; Fahlgren A; Fällman M
Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
McPhee JB; Mena P; Zhang Y; Bliska JB
Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8⁺ T cells responding to infection.
Bergsbaken T; Bevan MJ
Nat Immunol; 2015 Apr; 16(4):406-14. PubMed ID: 25706747
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes.
Rosenheinrich M; Heine W; Schmühl CM; Pisano F; Dersch P
PLoS One; 2015; 10(8):e0136290. PubMed ID: 26296209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
